RVTY

In the past six months, Revvity's stock (RVTY) has shown significant upward momentum, trending up by 70.44% and reaching a new 52-week high of $166.25 on October 7, 2026. This performance was driven by strong Q2 2026 earnings, where adjusted EPS of $1.41 surpassed analyst estimates and revenue reached $729.69 million to $730 million. Following these results, the company raised its full-year revenue guidance to $2.85 billion and adjusted EPS guidance to $5.35 at the midpoint. Other key events include the declaration of a quarterly dividend of $0.07 per share, a strategic divestiture of its China immunodiagnostics business, and strong orders from AI customers building large datasets.